Prickett, Todd D.

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

Tran, E., Robbins, P. F., Lu, Y.-C., Prickett, T. D., Gartner, J. J., Jia, L., Pasetto, A., Zheng, Z., Ray, S., Groh, E. M., et al. (2016) · New England Journal of Medicine

Immunotherapy and Immune ResponsesCAR-T cell therapy research

Cited by 1,368

mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer

Cafri, G., Gartner, J. J., Zaks, T., Hopson, K., Levin, N., Paria, B. C., Parkhurst, M. R., Yossef, R., Lowery, F. J., Jafferji, M. S., et al. (2020) · Journal of Clinical Investigation

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 427

Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4

Program, N. C. S., Prickett, T. D., Agrawal, N. S., Wei, X., Yates, K. E., Lin, J. C., Wunderlich, J. R., Cronin, J. C., Cruz, P., Rosenberg, S. A., et al. (2009) · Nature Genetics

Melanoma and MAPK PathwaysCancer Genomics and Diagnostics

Cited by 352

A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers

Hanada, K.-I., Zhao, C., Gil-Hoyos, R., Gartner, J. J., Chow-Parmer, C., Lowery, F. J., Krishna, S., Prickett, T. D., Kivitz, S., Parkhurst, M. R., et al. (2022) · Cancer Cell

Cancer Immunotherapy and BiomarkersCAR-T cell therapy research

Cited by 200

Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4

Liu, J., Prickett, T. D., Elliott, E., Meroni, G., & Brautigan, D. L. (2001) · Proceedings of the National Academy of Sciences

Protein Tyrosine PhosphatasesMicrotubule and mitosis dynamics

Cited by 100